Article
Inter-tumor heterogeneity.
Human vaccines & immunotherapeutics - 1 Aug 2012
Cusnir Mike, Cavalcante Ludmila
Abstract excerpt
Advances in the molecular study of cancer have focused on biomarkers in the setting of tumor-driving mutations within the great heterogeneity of the tumor genomic landscape. It is clearly recognized now that even two tumors originating from the same organ even if histological they appear similar their behavior and response to therapy can be different. These findings have increased interest and research to find...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.